| Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance AJ Narayan, LA Downey, B Manning, AC Hayley Neuroscience & Biobehavioral Reviews 143, 104941, 2022 | 20 | 2022 |
| A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance B Manning, TR Arkell, AC Hayley, LA Downey Journal of Psychopharmacology 38 (3), 247-257, 2024 | 6 | 2024 |
| Effect of CannEpil® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial B Manning, AC Hayley, S Catchlove, B Shiferaw, C Stough, LA Downey Journal of psychopharmacology 37 (5), 472-483, 2023 | 6 | 2023 |
| A systematic review of oculomotor deficits associated with acute and chronic cannabis use B Manning, LA Downey, A Narayan, AC Hayley Addiction Biology 29 (1), e13359, 2024 | 4 | 2024 |
| A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20: 1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition … B Manning, AC Hayley, S Catchlove, C Stough, LA Downey European Neuropsychopharmacology 82, 35-43, 2024 | 3 | 2024 |
| A semi-naturalistic, open-label trial examining the effect of prescribed medical cannabis on neurocognitive performance TR Arkell, B Manning, LA Downey, AC Hayley CNS drugs 37 (11), 981-992, 2023 | 3 | 2023 |
| Response to ensuring safety in cannabinoid prescriptions: A call for critical assessment B Manning, AC Hayley, LA Downey European neuropsychopharmacology: the journal of the European College of …, 2024 | | 2024 |
| Open-label medicinal cannabis use effect on simulated driving performance B Manning, T Arkell, L Downey, A Hayley Australasian Road Safety Conference, 2023, Cairns, Queensland, Australia, 2023 | | 2023 |
